[Muscular pain and hypolipidaemic drugs: a cross-sectional study in cardiological outpatient practice]

Julie Biga1, Philippe Vigreux, Maryse Lapeyre-Mestre

  • 1Service de Pharmacologie Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Information sur le Médicament, Hôpitaux de Toulouse, Toulouse, France.

Therapie
|September 1, 2005
PubMed

Insights

Cardiology patients reported muscular pain, with no significant difference found between those taking hypolipidaemic drugs and those not. This includes statins and fibrates.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Context:

  • Investigating adverse drug reactions in cardiovascular patients.
  • Assessing the prevalence of muscular pain in a real-world clinical setting.
  • Understanding potential side effects of lipid-lowering therapies.

Purpose:

  • To determine the frequency of muscular pain reports among cardiology outpatients.
  • To compare the incidence of muscular pain in patients receiving hypolipidaemic drugs versus those not.

Summary:

  • A cross-sectional study of 510 cardiology outpatients in 2003 found 9.6% reported muscular pain.
  • Among patients on hypolipidaemic drugs, 11.3% experienced muscular pain (12% on statins, 8.2% on fibrates).
  • No significant difference in muscular pain frequency was observed between patients on hypolipidaemic drugs and those not.

Impact:

  • Provides data on muscular pain prevalence in cardiology outpatients.
  • Informs clinical practice regarding potential side effects of hypolipidaemic medications.
  • Highlights the need for continued monitoring of adverse events in cardiovascular pharmacotherapy.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...